Will AOH1996 succeed in Phase I trial?
88
1.6kṀ11k2027
73%
chance
1H
6H
1D
1W
1M
ALL
This market concerns AOH1996, a cancer therapeutic reported in this paper.
It is currently in Phase I trial.
This market resolves to YES, if a Phase II trial is submitted and starts for any type of cancer.
This question is managed and resolved by Manifold.
Get
1,000 to start trading!
People are also trading
Related questions
Will AOH1996 get FDA acceleration?
18% chance
Will AOH1996 advance past Phase II trials by the end of 2027?
43% chance
Will the pre-clinical results on the cancer drug AOH1996 be broadly confirmed by independent team(s)?
26% chance
When will the "100% effective against solid tumors" cancer pill AOH1996 be approved by the FDA?
Will AOH1996 be FDA approved before 2040?
40% chance
When will we confidently know whether AOH1996 is effective?
Will the Phase 3 Trials of Olpasiran be a Success?
55% chance
Will the UCSF AER002 phase 2 pilot trial show statistically significantly positive results?
38% chance
Will a drug designed with significant contribution from an AlphaFold-like system pass a Phase I trial by end of 2025?
19% chance
Will the Phase 2 Trials of Lepodisiran be a Success?
57% chance